OTCPicks.com Daily Market Movers Digest Midday Report for Wednesday, December 3rd SMAS, OGXI, LGVN, PWRM, GLUU, ASTI

Our Stocks to Watch today include Somatic Systems Inc. (OTC: SMAS), OncoGenex Pharmaceuticals Inc. (Nasdaq: OGXI), LogicVision Inc. (Nasdaq: LGVN), Power3 Medical Products Inc. (OTCBB: PWRM), Glu Mobile Inc. (Nasdaq: GLUU) and Ascent Solar Technologies Inc. (Nasdaq: ASTI).

SOMATIC SYSTEMS INCORPORATED (OTC: SMAS)

Somatic Systems is the worldwide center for Clinical Somatics™, the groundbreaking drug-free, non-surgical approach to pain relief. This proprietary system uses natural, non-invasive movement techniques — conducted through one-hour hands-on sessions, therapeutic exercises classes, and home exercises lasting as little as 5 minutes a day — to relieve pain and limitation resulting from accident, trauma and repetitive stress, including back pain, knee pain, joint problems, carpal tunnel syndrome, TMJ, scoliosis, bursitis, sciatica, headaches, tendonitis and more. Clinical Somatics™ also provides performance gains and injury prevention for casual and professional athletes. Somatic Systems is pursuing a 3-part growth strategy, consisting of a nationwide rollout of pain management Somatics Clinics; increased production and distribution of therapeutic videos, books, and other retail self-help Somatics Products; and expanded Somatics Training Programs to supply Clinic practitioners serving medical and orthopedic professionals and institutional and corporate programs. The company operates a suite of web sites offering Somatics information, products, resources and opportunities at www.somatics.org.

ONCOGENEX PHARMA INCORPORATED (NASDAQ: OGXI)

"Up 126.22% in morning trading"

OncoGenex Pharmaceuticals is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address unmet needs in the treatment of cancer. OncoGenex has a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OGX-011, the lead candidate currently completing five Phase 2 clinical studies in prostate, lung and breast cancers, is designed to inhibit the production of specific proteins associated with treatment resistance; OGX-427 and SN2310 are in Phase 1 clinical development; and CSP9222 and OGX-225 are currently in pre-clinical development.

LOGICVISION INCORPORATED (NASDAQ: LGVN)

"Up 65.31% in morning trading"

LogicVision, Inc. provides technology for the design and manufacture of semiconductor devices. It offers a portfolio of products for the automated development, integration, and deployment of embedded test technology, which consists of technology products, design software products, and manufacturing software products. The company's technology products include the embedded test technology that enables customers to design and manufacture the company's embedded test circuit structures. Its design software products comprise a suite of embedded test design software tools for embedded test implementation on application specific integrated circuits and system-on-a-chip (SoC) designs. The company offers manufacturing software products for access and control of embedded test during chip, and system test program development, debug, manufacturing test, and datalogging. Its technology allows semiconductor designers to insert test structures inside semiconductor integrated circuits, and test the functionality and performance of their devices. The company also provides maintenance, design, and technology development contract services. LogicVision licenses its technologies and software products to companies in semiconductor, semiconductor diagnostics, and systems industries. The company serves application specific integrated circuit or SoC designers in systems and fabless companies, and integrated device manufacturers. It sells its products directly, as well as through distributors or independent sales representatives in the United States and internationally. The company was founded in 1992. It was formerly known as LV Software and changed its name to LogicVision, Inc. in 1996. LogicVision is based in San Jose, California.

POWER 3 MEDICAL PRODUCTS INCORPORATED (OTCBB: PWRM)

"Up 30.77% in morning trading"

Power3 Medical Products Inc. is a leading Bio Medical company engaged in the commercialization of cancer and neurodegenerative disease biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. Power3's patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets. Power3 operates a state-of-the-art CLIA certified laboratory in The Woodlands (Houston), Texas. The Company continues to evolve and enhance its IP portfolio.

GLU MOBILE INCORPORATED (NASDAQ: GLUU)

"Up 29.17% in morning trading"

Glu (Nasdaq: GLUU) is a leading global publisher of mobile games. Its portfolio of top-rated games includes original titles Super K.O. Boxing!, Stranded and Brain Genius, and titles based on major brands from partners including Atari, Activision, Konami, Harrah's, Hasbro, Warner Bros., Microsoft, PlayFirst, PopCap Games, SEGA and Sony. Founded in 2001, Glu is based in San Mateo, Calif. and has offices in London, France, Germany, Spain, Italy, Sweden, Poland, Russia, China, Brazil, Chile, Canada and Mexico.

ASCENT SOLAR TECHNOLOGIES INCORPORATED (NASDAQ: ASTI)

"Up 20.50% in morning trading"

Ascent Solar Technologies, Inc. is a developer of thin-film photovoltaic modules with substrate materials that can be more flexible and affordable than most traditional solar panels. Ascent Solar modules can be directly integrated into standard building materials, space applications, consumer electronics for portable power or configured as stand alone modules for large scale terrestrial deployment. Ascent Solar is located in Littleton, Colorado.

About OTCPicks.com

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Disclosure: OTCPicks.com has been compensated sixty million free trading shares from a third party for SMAS advertising and promotional activities.

OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.